Spandidos Publications style
Kadivar A, Noordin MI, Aditya A, Kamalidehghan B, Davoudi ET, Sedghi R and Javar HA: [Corrigendum] Antiproliferative effects of imatinib mesylate on ZR‑75‑1 and MDA‑MB‑231 cell lines via PDGFR‑β, PDGF‑BB, c‑Kit and SCF expression. Int J Mol Med 43: 2259-2259, 2019.
APA
Kadivar, A., Noordin, M.I., Aditya, A., Kamalidehghan, B., Davoudi, E.T., Sedghi, R., & Javar, H.A. (2019). [Corrigendum] Antiproliferative effects of imatinib mesylate on ZR‑75‑1 and MDA‑MB‑231 cell lines via PDGFR‑β, PDGF‑BB, c‑Kit and SCF expression. International Journal of Molecular Medicine, 43, 2259-2259. https://doi.org/10.3892/ijmm.2019.4119
MLA
Kadivar, A., Noordin, M. I., Aditya, A., Kamalidehghan, B., Davoudi, E. T., Sedghi, R., Javar, H. A."[Corrigendum] Antiproliferative effects of imatinib mesylate on ZR‑75‑1 and MDA‑MB‑231 cell lines via PDGFR‑β, PDGF‑BB, c‑Kit and SCF expression". International Journal of Molecular Medicine 43.5 (2019): 2259-2259.
Chicago
Kadivar, A., Noordin, M. I., Aditya, A., Kamalidehghan, B., Davoudi, E. T., Sedghi, R., Javar, H. A."[Corrigendum] Antiproliferative effects of imatinib mesylate on ZR‑75‑1 and MDA‑MB‑231 cell lines via PDGFR‑β, PDGF‑BB, c‑Kit and SCF expression". International Journal of Molecular Medicine 43, no. 5 (2019): 2259-2259. https://doi.org/10.3892/ijmm.2019.4119
